Cargando…

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy

Immunotherapy is a potential way to save the lives of patients with bladder cancer, but it only benefits approximately 20% of them. A total of 4,028 bladder cancer patients were collected for this study. Unsupervised non-negative matrix factorization and the nearest template prediction algorithms we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Jialin, Lu, Xiaofan, Zhou, Yujie, Zhang, Meng, Ge, Qintao, Zhou, Jun, Hao, Zongyao, Gao, Shenglin, Yan, Fangrong, Liang, Chaozhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900642/ https://www.ncbi.nlm.nih.gov/pubmed/33665361 http://dx.doi.org/10.1016/j.omto.2021.02.001

Ejemplares similares

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
por: Meng, Jialin, et al.
Publicado: (2021)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2020)

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature
por: Lu, Xiaofan, et al.
Publicado: (2021)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
por: Meng, Jialin, et al.
Publicado: (2022)

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
por: Lu, Xiaofan, et al.
Publicado: (2021)

EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort
por: Ge, Qintao, et al.
Publicado: (2022)

Tumour microenvironment‐based molecular profiling reveals ideal candidates for high‐grade serous ovarian cancer immunotherapy
por: Lu, Xiaofan, et al.
Publicado: (2021)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
por: Huang, Mengjia, et al.
Publicado: (2021)

Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour
por: Meng, Jialin, et al.
Publicado: (2022)

Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review
por: Meng, Jialin, et al.
Publicado: (2018)

A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study
por: Hu, Yongtao, et al.
Publicado: (2022)

Nomogram for predicting the overall survival of patients with early‐onset prostate cancer: A population‐based retrospective study
por: Hu, Yongtao, et al.
Publicado: (2022)

In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
por: Zhang, Meng, et al.
Publicado: (2023)

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis
por: Xu, Hanjiang, et al.
Publicado: (2022)

Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis
por: Zhang, Meng, et al.
Publicado: (2017)

Establishment of a tumor immune microenvironment-based molecular classification system of breast cancer for immunotherapy
por: Zheng, Xiaobo, et al.
Publicado: (2021)

Signature for Prostate Cancer Based on Autophagy-Related Genes and a Nomogram for Quantitative Risk Stratification
por: Wen, Chenghao, et al.
Publicado: (2022)

Higher Intake of Fat, Vitamin E-(β+γ), Magnesium, Sodium, and Copper Increases the Susceptibility to Prostatitis-like Symptoms: Evidence from a Chinese Adult Cohort
por: Zhang, Meng, et al.
Publicado: (2022)

Metabolomics Analysis Reveals the Differential Metabolites and Establishes the Therapeutic Effect Prediction Nomogram Among CP/CPPS Patients Who Respond or Do Not Respond to LiST
por: Meng, Jialin, et al.
Publicado: (2022)

Prevalence Rate and Risk Factors of Depression in Outpatients with Premature Ejaculation
por: Zhang, Xiansheng, et al.
Publicado: (2013)

Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy
por: Yu, Meng, et al.
Publicado: (2019)

The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2019)

Comprehensive Review of Genetic Association Studies and Meta-Analysis on polymorphisms in microRNAs and Urological Neoplasms Risk
por: Zhang, Ligang, et al.
Publicado: (2018)

HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP
por: Chen, Jing, et al.
Publicado: (2022)

RNA processing genes characterize RNA splicing and further stratify colorectal cancer
por: Lu, Xiaofan, et al.
Publicado: (2020)

Clinical Features of 167 Inpatients with Autosomal Dominant Polycystic Kidney Disease at a Single Center in China
por: Meng, Jialin, et al.
Publicado: (2018)

p27-V109G Polymorphism Is Not Associated with the Risk of Prostate Cancer: A Case-Control Study of Han Chinese Men in Central China
por: Zhang, Meng, et al.
Publicado: (2018)

Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
por: Liu, Jingchao, et al.
Publicado: (2022)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer
por: Chen, Lei, et al.
Publicado: (2022)

Single‐cell multi‐omics analysis presents the landscape of peripheral blood T‐cell subsets in human chronic prostatitis/chronic pelvic pain syndrome
por: Zhang, Meng, et al.
Publicado: (2020)

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
por: Xie, Feng, et al.
Publicado: (2019)

Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis
por: Lu, Xiaofan, et al.
Publicado: (2020)

Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer
por: Jia, Xiaolong, et al.
Publicado: (2023)

Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies
por: Adegoke, Nurudeen A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ukfl5a3unn5i20mfvk8qa3qsg7